A randomized controlled trial of cell salvage in routine cardiac surgery

Anesthesia and Analgesia

Volumn 107, Issue 5, 2008, Pages 1487-1495

  Klein, Andrew A ^a   Nashef, Samer A M ^a   Sharples, Linda ^b   Bottrill, Fiona ^a   Dyer, Matthew ^c   Armstrong, Johanna ^a   Vuylsteke, Alain ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

^c BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; HEPARIN; ISOFLURANE; MORPHINE; PANCURONIUM; PROPOFOL; PROTAMINE; SCOPOLAMINE; TRANEXAMIC ACID;

AGED; ALLOTRANSPLANTATION; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; BLOOD SAMPLING; BLOOD TRANSFUSION; CARDIAC PATIENT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; COST EFFECTIVENESS ANALYSIS; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE COST; HEART VALVE REPLACEMENT; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SURGICAL PATIENT; AORTA VALVE; BLEEDING; HEART ARREST; HEART SURGERY; INTRAOPERATIVE PERIOD; METHODOLOGY; MIDDLE AGED;

AGED; AORTIC VALVE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY BYPASS; ERYTHROCYTE TRANSFUSION; HEART ARREST; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTRAOPERATIVE PERIOD; MIDDLE AGED;

EID: 56149126435     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181831e54     Document Type: Article

References (27)

1. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion Med-Blood transfusion. N Engl J Med 1999;340:438-47
2. Saving and improving lives - National Blood Service. Annual report 2004 (www.blood.co.uk/pdfdocs/annual-report-2004.pdf)
3. Brand A. Immunological aspects of blood transfusions. Transpl Immunol 2002;10:183-90
4. Brander L, Reil A, Bux J, Taleghani BM, Regli B, Takala J. Severe transfusion-related acute lung injury. Anesth Analg 2005;101:499 -501
5. Spiess BD, Ley C, Body SC, Siegel LC, Stover EP, Maddi R, D'Ambra M, Jain U, Liu F, Herskowitz A, Mangano DT, Levin J. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. McSPI Research Group. J Thorac Cardiovasc Surg 1998;116:460-7
6. Surgenor SD, DeFoe, GR, Fillinger MP, Likosky DS, Groom RC, Clark C, Helm RE, Kramer RS, Leavitt BJ, MD, Klemperer JD, Krumholz CF, Westbrook BM, Galatis DJ, Frumiento C, Ross CS, Olmstead EM, O'Connor GT. Intraoperative red blood cell transfusion during coronary artery bypass graft surgery increases the risk of postoperative low-output heart failure. Circulation 2006;114:43-8
7. Karkouti K, Wijeysundera DN, YauTM, Beattie SW, Abdelnaem E, McCluskey SA, Ghannam M, Yeo E, Djaiani G, Karski J. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004;44:1453-62
8. Forgie M, Wells P, Laupacis A, Fergusson D. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red cell transfusion - results of a meta analysis. Arch Intern Med 1998;158:610-16
9. Ferraris VA, Ferraris SP, Saha SP, Hassel EA, Haan CK, Royston BD, Bridges CR, Higgins RSD, Despotis G, Brown JR. Perioperative blood transfusion & blood conservation in cardiac surgery. The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline. Ann Thorac Surg 2007;83:S27-S8610
10. Karkouti K, Beattie WS, Dattilo KM, McCluskey SA, Ghannam M, Hamdy A, Wijeysundera DN, Fedorko L, Yau TM. Blood conservation and transfusion alternatives. Transfusion 2006;46:327-38
11. McGill M, O'Shaughnessy D, Pickering R, Herbertson M, Gill R. Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial. BMJ 2002;324:1299-306
12. Murphy GJ, Allen SM, Unsworth-White J, Lewis CT, Dalrymple- Hay MJR. Safety and Efficacy of Perioperative CS and Autotransfusion After Coronary Artery Bypass Grafting: A Randomized Trial. Ann Thorac Surg 2004;77: 1553-913
13. Diprose P, Herbertson MJ, O'Shaughnessy DO, Deakin CD, Gill RS. Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative CS. Br J Anaesth 2005;94:271-8
14. Carless PA, Henry DA, Moxey AJ, O'Connell DL, Brown T, Fergusson DA. Cell salvage for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2006; CD00188815
15. National prices 2007/8, National Blood Service.http://www.blood.co.uk/ hospitals/library/pdf/ncg-letter-Dec06-NBS--component-prices-2007-08.pdf
16. British Medical Association and the Royal Pharmaceutical Society of Great Britain. The Br National Formulary. Wallingford, UK, 2007:53
17. The New NHS 2005-2006 Reference Costs. Department of Health, 2006
18. Curtis L, Netten A. Unit costs of health & social care 2006. Personal social services research unit, University of Kent (Available at http://www.pssru.ac.uk/pdf/uc/uc2006/uc2006.pdf)
19. Roques F, Michel P, Goldstone AR, Nashef SA. The logistic EuroSCORE. Eur Heart J 2003;24:881-2
20. Mongan PD, Brown RS, Thwaites BK. Tranexamic acid and Aprotinin reduce postoperative bleeding and transfusions during primary coronary revascularization. Anesth Analg 1998;87:258 - 65
21. Niranjan G, Asimakopoulos G, Karagounis A, Cockerill G, Thompson M, Chandrasekaran V. Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial. Eur J Cardiothorac Surg 2006;30:271-7
22. Vuylsteke A, Gerrard C. BMJ 's cover and headline exaggerated importance of study's findings. BMJ 2002;325:655
23. Murphy GJ, Rogers CS, Landsdowne WB, Channon I, Alwair H, Cohen A, Caputo M, Angelini GD. Safety, efficacy, and cost of intraoperative CS and autotransfusion after off-pump coronary artery bypass surgery: a randomized trial. J Thorac Cardiovasc Surg 2005;130:20-8
24. Daane CR, Golab HD, Meeder JH, Wijers MJ, Bogers AJ. Processing and transfusion of residual cardiopulmonary bypass volume: effects hemostasis, complement activation, postoperative blood loss and transfusion volume. Perfusion 2003;18:115-21
25. Varney SJ, Guest JF. The annual cost of blood transfusions in the UK. Transfus Med 2003;13:205-18
26. Fraser RD, Boodhwani M, Thierry M, Wozny D, Wells G, Howard NJ; Cardiotomy Investigators. The cardiotomy trial: a randomized, double-blind study to assess the effect of processing of shed blood during cardiopulmonary bypass on transfusion and neurocognitive function. Circulation 2007;116(11 Suppl):I89 -I97
27. Djaiani G, Fedorko L, Borger MA, Green R, Carroll J, Marcon M, Karski J. Continuous flow cell saver reduces cognitive decline in elderly patients after coronary bypass surgery. Circulation 2007;116:1888-95